This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. African Americans with type 2 diabetes suffer high rates of heart disease. Risk factors for heart disease, such as high blood sugar, blood pressure, and cholesterol, can be controlled through medical management and changes in lifestyle behaviors. Taking care of diabetes and changing lifestyle behaviors can be difficult. Problem solving is one self-management tool deemed important for effective self-care of diabetes and for overcoming barriers to making the lifestyle changes essential for preventing or managing heart disease. But, methods for training problem solving and decision making for managing health have not been well established. This study will test a new questionnaire for measuring health-related problem-solving abilities and a new problem-solving training applied to self-management of diabetes and heart disease risk factors in African Americans with type 2 diabetes.
The specific aims are: 1) to assess the validity and reliability of a questionnaire of effective vs. ineffective health-related problem-solving ability (Health Problem-Solving Scale), 2) to develop a new intervention to teach health-related problem-solving skills to ineffective problem solvers, and 3) to conduct a pilot study with a sample of participants who have a high risk for heart disease AND ineffective health-related problem-solving skills, to test whether a brief vs. an intensive health problem-solving training improves problem solving ability, health behaviors, and heart disease risk factors. Participants are urban African Americans with type 2 diabetes. The research will be conducted in two parts, Health Problem-Solving Scale development (Study 1) and Health Problem-Solving Intervention (Study 2). Eligibility criteria for Study 1 include Low CVD Risk Profile (defined in this research proposal as optimal control of blood pressure, cholesterol, and blood sugar), or a High CVD Risk Profile (defined as high blood pressure, and/or high cholesterol, and/or high blood sugar). Participants will complete the Health Problem-Solving Scale and additional tests of problem solving and behavior. Upon completion of the Health Problem-Solving Scale questionnaire validation study, 60 participants who meet criteria for high CVD risk, and who score with a range of ineffective problem solving on the Health Problem-Solving Scale, will be participants in Study 2, the problem-solving training study. Participants will be randomly assigned, like flipping a coin, into either a Minimal Intervention group or an Intensive Intervention group. The Minimal Intervention group will receive Heart Disease Risk Education class + Brief Health Problem-Solving Training (2 weekly group sessions and 1 telephone follow-up). The Intensive Intervention Group will receive the Heart Disease Risk Education class + Intensive Health Problem-Solving Training (9 weekly group sessions and 1 telephone follow-up). At baseline and at 6 months after the intervention groups have ended, participants will have their blood sugar (HbA1c), cholesterol, and blood pressure assessed. In addition, they will complete questionnaires about problem solving, self-management adherence, knowledge, health behaviors, progress toward CVD risk management goals, and quality of life.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
General Clinical Research Centers Program (M01)
Project #
5M01RR000052-45
Application #
7378931
Study Section
Special Emphasis Panel (ZRR1-CR-1 (01))
Project Start
2005-12-01
Project End
2006-11-30
Budget Start
2005-12-01
Budget End
2006-11-30
Support Year
45
Fiscal Year
2006
Total Cost
$1,918
Indirect Cost
Name
Johns Hopkins University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Al-Sofiani, Mohammed E; Yanek, Lisa R; Faraday, Nauder et al. (2018) Diabetes and Platelet Response to Low-Dose Aspirin. J Clin Endocrinol Metab 103:4599-4608
Grover, Surbhi; Desir, Fidel; Jing, Yuezhou et al. (2018) Reduced Cancer Survival Among Adults With HIV and AIDS-Defining Illnesses Despite No Difference in Cancer Stage at Diagnosis. J Acquir Immune Defic Syndr 79:421-429
Grams, Morgan E; Sang, Yingying; Ballew, Shoshana H et al. (2018) Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate. Kidney Int 93:1442-1451
Yanik, Elizabeth L; Hernández-Ramírez, Raúl U; Qin, Li et al. (2018) Brief Report: Cutaneous Melanoma Risk Among People With HIV in the United States and Canada. J Acquir Immune Defic Syndr 78:499-504
Aboud, Katherine S; Barquero, Laura A; Cutting, Laurie E (2018) Prefrontal mediation of the reading network predicts intervention response in dyslexia. Cortex 101:96-106
Kattan, Meyer; Bacharier, Leonard B; O'Connor, George T et al. (2018) Spirometry and Impulse Oscillometry in Preschool Children: Acceptability and Relationship to Maternal Smoking in Pregnancy. J Allergy Clin Immunol Pract 6:1596-1603.e6
Altekruse, Sean F; Shiels, Meredith S; Modur, Sharada P et al. (2018) Cancer burden attributable to cigarette smoking among HIV-infected people in North America. AIDS 32:513-521
Salemi, Parissa; Skalamera Olson, Julie M; Dickson, Lauren E et al. (2018) Ossifications in Albright Hereditary Osteodystrophy: Role of Genotype, Inheritance, Sex, Age, Hormonal Status, and BMI. J Clin Endocrinol Metab 103:158-168
Robert Braši?, James; Mari, Zoltan; Lerner, Alicja et al. (2018) Remission of Gilles de la Tourette Syndrome after Heat-Induced Dehydration. Int J Phys Med Rehabil 6:
Altman, Matthew C; Whalen, Elizabeth; Togias, Alkis et al. (2018) Allergen-induced activation of natural killer cells represents an early-life immune response in the development of allergic asthma. J Allergy Clin Immunol 142:1856-1866

Showing the most recent 10 out of 1014 publications